KRISTEN GEIS: Open Payments
NPI 1316728306 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 40 payments from 11 companies in 2025. Trend: 2023 $44 · 2024 $770 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $216 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $47 |
| Lundbeck LLC | 2 | $29 |
| PFIZER INC. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Abbott Laboratories | 1 | $9 |
Products named: VRAYLAR, REXULTI, QULIPTA, MOUNJARO, LINZESS, UBRELVY, ELIQUIS, Dexcom G6 Transmitter.
Industry payments across KS — which companies pay providers there.
